Top Biomanufacturing Companies in Europe

Monday, August 17, 2026

Advancements in drug development are encouraging pharmaceutical organisations in Europe to strengthen their focus on research-driven therapeutic approaches and specialised treatment platforms. Clinical stage pharmaceutical and therapeutics develops solutions that aid in the progression of promising drug candidates through key development phases while solving complex medical needs across targeted therapeutic areas. Such firms are strengthening the clinical research field, increasing therapy evaluation procedures and also helping enhance the establishment of targeted treatments to ensure much more deliverable specific health care. Growing collaboration between biotechnology firms,

Tuesday, August 11, 2026

Expanding production capacity is not always a matter of adding equipment. For companies involved in xenogenic biomaterial design and manufacturing across Europe, growth plans may be influenced by a less visible factor: access to specialized expertise. The sector operates at the intersection of biological science, manufacturing processes and quality oversight. That combination creates workforce requirements that can be difficult to satisfy, particularly as organizations expand development activities or move toward larger-scale production. Finding the right talent can be particularly difficult in specialized fields such as biomaterials. Companies often look for professio

Tuesday, August 11, 2026

An unexplained death investigation often starts with very little to go on. There may be no clear medical cause, limited information from the scene, no reliable witness account and no obvious physical explanation. That can leave the coroner or pathologist with a difficult question: did a substance play a role, or can toxicology help rule it out? Choosing a laboratory service therefore involves more than selecting a testing panel. The service needs to work effectively when important details are missing, without allowing that uncertainty to result in delays or inconclusive interpretation. Drug-related deaths are also becoming more difficult to investigate. Routine screening remains

Monday, August 03, 2026

Cell and gene therapy has become one of the most influential areas in modern medicine. Unlike conventional treatments that primarily manage symptoms, these therapies aim to address the biological causes of disease. Their potential to deliver long-lasting and, in some cases, curative outcomes has shifted the conversation from scientific possibility to clinical reality. Healthcare organizations, investors and policymakers now view the category as an important part of the future treatment landscape. Cell therapy is a form of medical treatment that uses cells for regeneration, replacement or enhancement of biological functions. Gene therapy involves introducing, manipulating or repl

Monday, July 27, 2026

Fremont, CA: Clinical research across Europe is undergoing a structural shift as healthcare systems, research institutions, and life sciences organisations rethink how studies are conducted and evaluated. The environment surrounding research has become more complex, influenced by regulatory expectations, expanding data ecosystems, and a stronger emphasis on patient perspectives. Instead of relying solely on traditional study models, stakeholders are integrating new analytical capabilities and broader data sources to strengthen decision-making. These developments are not merely technological adjustments but reflect bigger changes in how research priorities are de

Tuesday, July 21, 2026

In their roles, they will support the continued evolution of the company as a technology and patient-first business Inventus, the only company in the world dedicated to creating purpose-bult devices and technology solutions exclusively for clinical trials, has today announced two key appointments. Jon French, Managing Director at Google and Stacy Hurt, Chief Patient Officer at Parexel have been selected to join the Inventus Board as Non-Executive Advisers. Both bring a wealth of experience wh